Olumuyiwa A Bamgbade1, Oluwafemi Oluwole2, Rong R Khaw3. 1. Department of Anaesthesia, University of British Columbia, Vancouver, BC, Canada. olu.bamgbade@gmail.com. 2. Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada. 3. Department of Surgery, University of Manchester, Manchester, UK.
Abstract
BACKGROUND: Postoperative pain and analgesia present challenges in bariatric surgery patients. Multimodal analgesia may provide better efficacy, less complications and expedite fast-track bariatric surgical care. There are no studies of the broader topic of perioperative analgesia and the overall impact. This study highlights the impact of multimodal intraoperative analgesia on fast-track bariatric surgery. METHODS: This observational study examined the perioperative outcome data of 412 consecutive laparoscopic bariatric surgery patients over a 6-year period. Perioperative outcome and variables were analysed and compared between different intraoperative analgesia types. RESULTS: Mean BMI was 49, mean age was 42 and male:female ratio was 1:4. About 82% of patients received multimodal intraoperative analgesia, comprising various combinations of bupivacaine infiltration and intravenous acetaminophen, morphine, tramadol, parecoxib or diclofenac. Morphine was administered in 83% of patients and tramadol in 17%. Multimodal intraoperative analgesia provided better postoperative analgesia, shorter postanaesthesia care unit (PACU) duration, lower postoperative opioid requirement, less postoperative vomiting, earlier postoperative oral intake, earlier ambulation and shorter hospital stay compared to unimodal intraoperative morphine analgesia (p = 0.0001). Multimodal analgesia comprising tramadol + acetaminophen + diclofenac provided better postoperative analgesia, shorter PACU duration, lower postoperative opioid requirement, earlier ambulation, shorter hospital stay and less postoperative hypopnoea compared to patients who received morphine (p = 0.0001). CONCLUSIONS: Multimodal intraoperative analgesia provides better postoperative analgesia, less complications and better perioperative outcomes and facilitates fast-track bariatric surgical care. Tramadol is suitable, efficacious and safe and associated with the best perioperative outcomes in bariatric surgery patients.
BACKGROUND:Postoperative pain and analgesia present challenges in bariatric surgery patients. Multimodal analgesia may provide better efficacy, less complications and expedite fast-track bariatric surgical care. There are no studies of the broader topic of perioperative analgesia and the overall impact. This study highlights the impact of multimodal intraoperative analgesia on fast-track bariatric surgery. METHODS: This observational study examined the perioperative outcome data of 412 consecutive laparoscopic bariatric surgery patients over a 6-year period. Perioperative outcome and variables were analysed and compared between different intraoperative analgesia types. RESULTS: Mean BMI was 49, mean age was 42 and male:female ratio was 1:4. About 82% of patients received multimodal intraoperative analgesia, comprising various combinations of bupivacaine infiltration and intravenous acetaminophen, morphine, tramadol, parecoxib or diclofenac. Morphine was administered in 83% of patients and tramadol in 17%. Multimodal intraoperative analgesia provided better postoperative analgesia, shorter postanaesthesia care unit (PACU) duration, lower postoperative opioid requirement, less postoperative vomiting, earlier postoperative oral intake, earlier ambulation and shorter hospital stay compared to unimodal intraoperative morphineanalgesia (p = 0.0001). Multimodal analgesia comprising tramadol + acetaminophen + diclofenac provided better postoperative analgesia, shorter PACU duration, lower postoperative opioid requirement, earlier ambulation, shorter hospital stay and less postoperative hypopnoea compared to patients who received morphine (p = 0.0001). CONCLUSIONS: Multimodal intraoperative analgesia provides better postoperative analgesia, less complications and better perioperative outcomes and facilitates fast-track bariatric surgical care. Tramadol is suitable, efficacious and safe and associated with the best perioperative outcomes in bariatric surgery patients.
Authors: Toby N Weingarten; Juraj Sprung; Antolin Flores; Ana M Oviedo Baena; Darrell R Schroeder; David O Warner Journal: Obes Surg Date: 2011-09 Impact factor: 4.129
Authors: Rafael Moncada; Linas Martinaitis; Manuel Landecho; Fernando Rotellar; Carlos Sanchez-Justicia; Manuel Bellver; Magdalena de la Higuera; Camilo Silva; Beatriz Osés; Elena Martín; Susana Pérez; Jose Luis Hernandez-Lizoain; Gema Frühbeck; Victor Valentí Journal: Obes Surg Date: 2016-02 Impact factor: 4.129
Authors: Shireesh Saurabh; Jessica K Smith; Mark Pedersen; Paul Jose; Peter Nau; Isaac Samuel Journal: Surg Obes Relat Dis Date: 2014-09-30 Impact factor: 4.734
Authors: Saskia L Boerboom; Ann de Haes; Lianne Vd Wetering; Edo O Aarts; Ignace M C Janssen; Jose W Geurts; Ed T Kamphuis Journal: Obes Surg Date: 2018-10 Impact factor: 4.129
Authors: Jun Jie Ng; Wei Qi Leong; Chuen Seng Tan; Keah How Poon; Davide Lomanto; Jimmy B Y So; Asim Shabbir Journal: Obes Surg Date: 2017-12 Impact factor: 4.129
Authors: Nicola Di Lorenzo; Stavros A Antoniou; Rachel L Batterham; Luca Busetto; Daniela Godoroja; Angelo Iossa; Francesco M Carrano; Ferdinando Agresta; Isaias Alarçon; Carmil Azran; Nicole Bouvy; Carmen Balaguè Ponz; Maura Buza; Catalin Copaescu; Maurizio De Luca; Dror Dicker; Angelo Di Vincenzo; Daniel M Felsenreich; Nader K Francis; Martin Fried; Berta Gonzalo Prats; David Goitein; Jason C G Halford; Jitka Herlesova; Marina Kalogridaki; Hans Ket; Salvador Morales-Conde; Giacomo Piatto; Gerhard Prager; Suzanne Pruijssers; Andrea Pucci; Shlomi Rayman; Eugenia Romano; Sergi Sanchez-Cordero; Ramon Vilallonga; Gianfranco Silecchia Journal: Surg Endosc Date: 2020-04-23 Impact factor: 4.584
Authors: Matthew Lange; Christina W Lee; Tara Knisely; Subbaiah Perla; Kimberly Barber; Michael Kia Journal: Bariatr Surg Pract Patient Care Date: 2018-09-01 Impact factor: 0.607